Some IBD Patients Have Increased Skin Cancer Risk

Past research has cautioned about the risk of skin cancer with use of immunosuppressive medications. Yet, a new study pointed out, there is limited information on repeated basal cell cancer (BCC) occurrences among inflammatory bowel disease (IBD) patients, especially those who use immunosuppressive medications.

Surveillance, Barriers to Care Key to Federal Medicine Fight Against HCC

Mortality rates from most cancers have declined in recent years, but deaths from hepatocellular carcinoma continue to climb. Both the VA and the DoD are moving aggressively to detect and treat liver disease before it progresses to hepatocellular carcinoma (HCC) and to quickly identify patients who have developed this devastating disease.

Houston, Miami VAMCs Participate in Tocilizumab Trial

HOUSTON—The Michael E. DeBakey VAMC in Houston and the Bruce W. Carter VAMC in Miami are among nearly 70 locations across the world participating in a randomized double-blind clinical trial of an immunomodulator, tocilizumab, for patients with severe pneumonia...

VA Launches COVID-19 Insights Partnership with DOE and HHS

NEW HAVEN, CT—The VA along with the Departments of Energy (DOE) and Health and Human Services (HHS) have established a partnership to share health data, research, and expertise in the battle against COVID-19. VA and HHS will use the DOE’s high-speed computing...